Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 57 announcements

Biocon Ltd news stories on ALFA NewsRead the news →
Share price
₹360.00
Market cap
₹58,669 Cr
Revenue (annual)
₹16,927 Cr
Net profit (annual)
₹385.6 Cr
P/E (TTM)
118.5×Sector 47.4×
Promoter holding
44.68%-0.23% QoQ
FII holding
8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Regulatory Approval 6Earnings Call 6Annual General Meeting 6Other Announcement 4Capital Structure Change 4Business Update 4New Order Win 3Management Change 3Fund Raise 3Financial Results 3Results Update 2Product Launch 2Merger & Restructuring 2Board Meeting Outcome 2Board Meeting Date 2Acquisition 2Price Movement Clarification 1Dividend 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

19:47 IST NSE
Board Meeting Outcome

Biocon Board Meeting Outcome

Biocon Limited has scheduled a Board Meeting on May 7, 2026, to consider audited standalone and consolidated financial results for the year ended March 31, 2026. The board will also consider a recommendation for a final dividend. The trading window for designated persons remains closed until May 9, 2026.

Read the filing ↗
19:41 IST BSE
Board Meeting Outcome

Biocon Board Meeting Outcome

Biocon Ltd will hold a Board Meeting on May 07, 2026, to approve audited financial results for the fiscal year ended March 31, 2026, and recommend a dividend. An earnings conference call is scheduled for May 08, 2026. The trading window for designated persons remains closed until May 09, 2026.

Read the filing ↗